View drug registration information details.
| Items | Registration information |
|---|
| ID | 1684 |
|---|
| No | 1684 |
|---|
| Brand Name | LUCIAPLE |
|---|
| Ingredients | ALPELISIB 150 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 28'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF POSTMENOPAUSUAL WOMEN, AND MEN WITH HORMONE RECEPTOR POSITIVE, HYMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE, PIK3CA MUTED, ADVANCED OR METASTATIC BREAST CANCER. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | BROWNISH -RED OVAL COATED TABLET, EMBOSSED LUCIUS ON ONE SIDE AND ANOTHER SIDE IS PLAIN |
|---|
| Note | |
|---|
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 L 1076/24 |
|---|
| FDD Registration Date | 14-MAR-2023 |
|---|
| Expiry Date | 13-MAR-2027 |
|---|
Back to drug list
|
